Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
NCT ID: NCT06064838
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2023-08-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cocoa Supplementation, Inflammaging, and Epigenetic Aging
NCT05510375
Effect of CoQ10 Plus Selenium Supplementation on Clinical Outcomes and Biochemical Markers in ME/CFS (CoSeME Study)
NCT05128292
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
NCT00541164
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
NCT02030964
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
NCT00953849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The variables to consider will be: Interleukins (IL-1b, IL-6), Tumoral Necrosis Factor alpha (TNF-α) and syndecan-1.
For physical performance is evaluated the handgrip strength. The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire, and the numerical fatigue rating scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavonoids
Capsules with 500mg of cacao flavonoids, twice a day for 90 days
Flavonoids
1 capsule every 12h for 90 days
Placebo
Capsules with 500mg of excipients, twice a day for 90 days
Flavonoids
1 capsule every 12h for 90 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavonoids
1 capsule every 12h for 90 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic fatigue
Exclusion Criteria
* Pregnancy or lactation
* BMI \>35
* chronic liver disease
* chronic kidney disease
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
OTHER_GOV
Guillermo Ceballos Reyes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guillermo Ceballos Reyes
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
C.E. Indianilla
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLALOC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.